Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on September 30, 2004

Arteriosclerosis, Thrombosis, and Vascular Biology. 2004
Published online before print September 30, 2004, doi: 10.1161/01.ATV.0000146814.81581.68
A more recent version of this article appeared on January 1, 2005
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/1/84    most recent
01.ATV.0000146814.81581.68v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bulin, C.
Right arrow Articles by Fischer, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bulin, C.
Right arrow Articles by Fischer, J. W.

Submitted on May 19, 2004
Accepted on August 24, 2004

Differential Effects of Vasodilatory Prostaglandins on Focal Adhesions, Cytoskeletal Architecture, and Migration in Human Aortic Smooth Muscle Cells

C. Bulin ; U. Albrecht ; J. G. Bode ; A.-A. Weber ; K. Schrör ; B. Levkau ; and J. W. Fischer *

From the Molekulare Pharmakologie, Institut für Pharmakologie und Klinische Pharmakologie, Klinik für Gastroenterologie (C.B., U.A.), Hepatologie und Infektiologie, Heinrich Heine Universität Düsseldorf; Institut für Pathophysiologie (K.S.), Universitätsklinikum Essen, Germany.

* To whom correspondence should be addressed. E-mail: jens.fischer{at}uni-duesseldorf.de.

Objective--Cyclooxygenases 1 and 2 are expressed in atherosclerotic arteries, and local generation of prostacyclin and prostaglandin E2 (PGE2) occurs. However, the role of cyclooxygenases and individual prostaglandins during plaque progression is currently uncertain. The present study characterizes the effect of vasodilatory prostaglandins on morphology, focal adhesion (FA) function, and migration in human aortic smooth muscle cells (SMCs).

Methods and Results--The stable prostacyclin analog iloprost transiently induced: (1) disassembly of FA and stress fibers, (2) partial retraction and rounding of SMCs, (3) hypophosphorylation of FA kinase (FAK) and paxillin, and (4) inhibition of platelet-derived growth factor-BB-induced migration. Inhibition of FAK phosphorylation and morphological changes were mimicked by forskolin, inhibited by H89, and prevented by the protein tyrosine phosphatase inhibitor vanadate and by calpeptin. PGE2 was by far less efficient with respect to all parameters investigated. This difference correlated with the respective cAMP induction in response to iloprost and PGE2.

Conclusion--Inhibition of FAK phosphorylation and FA function is a new target of vasodilatory prostaglandins, which might be causally involved in the antimigratory effects of prostaglandins. Importantly, prostacyclin analogs and PGE2 differ dramatically with respect to dephosphorylation of FAK and inhibition of migration, which might be of relevance for their respective functions in atherosclerosis.


Key words: focal adhesion kinase • extracellular matrix • prostaglandins • atherosclerosis




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
K. Sattler and B. Levkau
Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection
Cardiovasc Res, May 1, 2009; 82(2): 201 - 211.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Pape, B. H. Rauch, A. C. Rosenkranz, G. Kaber, and K. Schror
Transcriptional Inhibition of Protease-Activated Receptor-1 Expression by Prostacyclin in Human Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 534 - 540.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. A. Bondesen, K. A. Jones, W. C. Glasgow, and G. K. Pavlath
Inhibition of myoblast migration by prostacyclin is associated with enhanced cell fusion
FASEB J, October 1, 2007; 21(12): 3338 - 3345.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. E. Thomas, M. Peters-Golden, E. S. White, V. J. Thannickal, and B. B. Moore
PGE2 inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L417 - L428.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. H. Rauch, G. A. Scholz, D. Baumgartel-Allekotte, P. Censarek, J. W. Fischer, A.-A. Weber, and K. Schror
Cholesterol Enhances Thrombin-Induced Release of Fibroblast Growth Factor-2 in Human Vascular Smooth Muscle Cells
Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): e20 - e25.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. S. Swaney, H. H. Patel, U. Yokoyama, B. P. Head, D. M. Roth, and P. A. Insel
Focal Adhesions in (Myo)fibroblasts Scaffold Adenylyl Cyclase with Phosphorylated Caveolin
J. Biol. Chem., June 23, 2006; 281(25): 17173 - 17179.
[Abstract] [Full Text] [PDF]